More than 1,500,000 people worldwide now live with kidney transplants, and there are thousands of failed transplants every year. Graft rejection is still a constant threat to patients. The consequences are immediate in terms of mortality and morbidity. Current research would reduce the number of rejections through more personalized monitoring and treatment.
Recipient data are collected in two ways. The first type of data concerns the patient's medical history and the medical data collected during the follow-up (blood and urine tests, histopathology of the biopsy, etc.). The second type of data concerns the evaluation of biomarkers of rejection in samples taken specifically for the study: blood proteins and RNA, urinary proteins and biopsy RNA.
|
No, there is no selection of patients to participate in the study. Patients are adults who have had a kidney transplant. These data are collected at the Nantes University Hospital, the Montpellier University Hospital, the Saint-Louis Hospital and the Necker Hospital in Paris, the Lyon Civil Hospital, the Bordeaux University Hospital and the Toulouse University Hospital.
|
Plan du site |
|
Site map |
ContactHôpital Européen Georges Pompidou
56, rue Leblanc 75908 Paris Cedex 15 contact@ktdinnov.fr Tel. +33 1 53 98 80 00 |
Subscribe to the NewsletterYou can unsubscribe at any time by clicking on the link at the bottom of our emails. By subscribing, your information will be transferred to Mailchimp. See Mailchimp's privacy practices. |
2022 © Copyright - Labs Explorer pour l'Inserm